School of Medicine


Showing 1-20 of 40 Results

  • Mark A. Cappelli

    Mark A. Cappelli

    Professor of Mechanical Engineering

    Bio Professor Cappelli received his B.Sc. degree in Physics (McGill, 1980), and M.A.Sc and Ph.D. degrees in Aerospace Sciences (Toronto, 1983, 1987). He joined Stanford University in 1987 and is currently a Professor in the Department of Mechanical Engineering and Co-Director of the Engineering Physics Program. He carries out research in applied plasma physics with applications to a broad range of fields, including space propulsion, aerodynamics, medicine, materials synthesis, and fusion.

  • Ian Carroll, MD, MS

    Ian Carroll, MD, MS

    Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) at the Stanford University Medical Center

    Current Research and Scholarly Interests We are committed to promoting an understanding of cerebrospinal fluid (CSF) leaks, and ensuring that all patients who are suffering from cerebrospinal fluid leaks receive appropriate diagnosis and treatment of this devastating, chronic, and fixable condition. We believe this can be best accomplished in a multidisciplinary setting involving expertise in radiology, neurology, and interventional pain medicine.

  • Chris Cartwright, MD

    Chris Cartwright, MD

    Professor of Medicine (Gastroenterology and Hepatology), Emerita

    Current Research and Scholarly Interests Molecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.

  • Alma-Martina Cepika

    Alma-Martina Cepika

    Instructor, Pediatrics - Stem Cell Transplantation

    Bio Dr. Cepika is an immunologist with an extensive background in translational research, autoimmunity, autoinflammation, and human systems immunology. Her goal is to understand the mechanisms governing immunological tolerance, and to leverage this knowledge to cure currently incurable diseases.

    Dr. Cepika received her MD degree and a PhD in Immunology from the University of Zagreb School of Medicine in Croatia. There, she focused on the immunomonitoring of patients with lupus, identifying how circulating DNA levels changed with therapy. Subsequently, she joined the lab of Dr. Virginia Pascual at the Baylor Institute for Immunology Research in Dallas, Texas. Dr. Pascual had previously discovered that IL-1beta is a key pathogenic player in systemic juvenile idiopathic arthritis (sJIA), but the immune alterations contributing to IL-1beta-mediated inflammation remained unknown. To address this, Dr. Cepika developed a 3D in vitro stimulation assay to evaluate immune responses of blood leukocytes of pediatric sJIA patients. In combination with integrated bioinformatics analysis, this approach identified aberrant cellular responses, transcriptional pathways and genes that shed new light on immune dysregulation in sJIA. This assay can be further applied to dissect underlying immunopathogenic mechanisms in many human disorders.

    Currently, Dr. Cepika is a member of the laboratory of Dr. Maria Grazia Roncarolo, in the Pediatric Division of Stem Cell Biology and Regenerative Medicine at Stanford University School of Medicine. There, she is working to uncover the underlying mechanisms governing type 1 regulatory T (Tr1) cell differentiation and function, and use this knowledge to design Tr1 cell-based therapies for hematopoietic stem cell transplantation, cancer immunotherapy and autoimmunity.

  • Anne Lynn S. Chang, MD

    Anne Lynn S. Chang, MD

    Professor of Dermatology at the Stanford University Medical Center

    Current Research and Scholarly Interests I have two main research interests:
    1) to better understand and treat patients with aggressive basal and squamous cell carcinomas
    2) to better understand the genetic and epigenetic mechanisms of healthy human skin aging and to translate these insights into better care of skin diseases enriched in older patients particularly skin cancer and rosacea

  • Daniel Chang

    Daniel Chang

    Sue and Bob McCollum Professor

    Current Research and Scholarly Interests I specialize in the treatment of gastrointestinal malignancies. I am interested in developing stereotactic body radiotherapy for tumors of the liver, both primary and metastatic. I am interested in developing functional imaging as a means of determining treatment response with radiation. I am also interested in developing image-guided radiotherapy to improve radiation delivery for GI cancers to reduce toxicity and improve disease outcome.

  • Howard Y. Chang, MD, PhD

    Howard Y. Chang, MD, PhD

    Virginia and D. K. Ludwig Professor of Cancer Research and Professor of Genetics

    Current Research and Scholarly Interests Our research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.

  • James K. Chen

    James K. Chen

    Jauch Professor and Professor of Chemical and Systems Biology, of Developmental Biology and of Chemistry

    Current Research and Scholarly Interests Our laboratory combines chemistry and developmental biology to investigate the molecular events that regulate embryonic patterning, tissue regeneration, and tumorigenesis. We are currently using genetic and small-molecule approaches to study the molecular mechanisms of Hedgehog signaling, and we are developing chemical technologies to perturb and observe the genetic programs that underlie vertebrate development.

  • Lu Chen

    Lu Chen

    Instructor, Stanford Cancer Institute

    Current Research and Scholarly Interests Lu's research path has a strong focus on molecular mechanisms underlying biological processes, with emphases on reproducibility, details, and precision. Trained with leading biochemists and cancer biologists, Lu's research tool-kit incorporates genetic engineering in human cells and model organisms, bridging his mechanistic discoveries to solving human diseases.

  • Alan G. Cheng

    Alan G. Cheng

    Edward C. and Amy H. Sewall Professor

    Current Research and Scholarly Interests Active Wnt signaling maintains somatic stem cells in many organ systems. Using Wnt target genes as markers, we have characterized distinct cell populations with stem cell behavior in the inner ear, an organ thought to be terminally differentiated. Ongoing work focuses on delineating the developing significance of these putative stem/progenitor cells and their behavior after damage.

  • Zhen Cheng

    Zhen Cheng

    Associate Professor (Research) of Radiology (Molecular Imaging)

    Current Research and Scholarly Interests To develop novel molecular imaging probes and techniques for non-invasively early detection of cancer using multimodality imaging technologies including PET, SPECT, MRI, optical imaging, etc.

  • Thomas L. Cherpes, DVM, MD

    Thomas L. Cherpes, DVM, MD

    Assistant Professor of Comparative Medicine

    Current Research and Scholarly Interests Directs an infectious disease laboratory that performs basic, translational, and clinical research. Laboratory has particular focus on:
    1) relationship between exogenous sex steroids on susceptibility to microbial pathogens
    2) role of Type 2 immunity in Chlamydia infection
    3) developing cellular immunotherapies to combat infectious disease and cancer

  • Athena Cherry

    Athena Cherry

    Member, Stanford Cancer Institute

    Current Research and Scholarly Interests The use of molecular and molecular cytogenetic methods to identify chromosomal abnormalities in acquired and congenital disorders.

  • Ramsey Cheung

    Ramsey Cheung

    Professor of Medicine (Gastroenterology and Hepatology) at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests Dr. Cheung's research interests focus on liver diseases, with emphasis on viral hepatitis. His past research include investigating the mechanism of viral neutralization of hepatitis B virus at the molecular level and immune response to hepatitis C virus. Dr. Cheung is studing various aspects of hepatitis C, both clinical and translational research.

  • Allis Chien

    Allis Chien

    Director, Stanford University Mass Spectrometry (SUMS), Mass Spectrometry Center

    Current Role at Stanford Director, Stanford University Mass Spectrometry (SUMS) core resource laboratory

  • Yueh-hsiu Chien

    Yueh-hsiu Chien

    Professor of Microbiology & Immunology

    Current Research and Scholarly Interests Contribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.

  • Frederick T. Chin, Ph.D.

    Frederick T. Chin, Ph.D.

    Assistant Professor (Research) of Radiology (Molecular Imaging)

    Current Research and Scholarly Interests Our group's primary objectives are:

    1) Novel radioligand and radiotracer development.
    We will develop novel PET (Positron Emission Tomography) imaging agents with MIPS and Stanford faculty as well as other outside collaborations including academia and pharmaceutical industry. Although my personal research interests will be to discover and design of candidate probes that target molecular targets in the brain, our group focus will primarily be on cancer biology and gene therapy. In conjunction with our state-of-the-art imaging facility, promising candidates will be evaluated by PET-CT/MR imaging in small animals and primates. Successful radioligands and/or radiotracers will be extended towards future human clinical applications.

    2) Designing new radiolabeling techniques and methodologies.
    We will aim to design new radiolabeling techniques and methodologies that may have utility for future radiopharmaceutical development in our lab and the general radiochemistry community.

    3) Radiochemistry production of routine clinical tracers.
    Since we also have many interests with many Stanford faculty and outside collaborators, our efforts will also include the routine radiochemistry production of many existing radiotracers for human and non-human use. Our routine clinical tracers will be synthesized in custom-made or commercial synthetic modules (i.e. GE TRACERlab modules) housed in lead-shielded cells and be distributed manually or automatically (i.e. Comecer Dorothea) to our imagers.

  • Albert Sean Chiou, MD, MBA

    Albert Sean Chiou, MD, MBA

    Clinical Assistant Professor, Dermatology

    Current Research and Scholarly Interests I am a clinical researcher interested in evaluating promising new diagnostic paradigms and treatments for serious or poorly treated, chronic skin conditions. My research currently includes:

    Therapeutics:

    - Treatments for itch from epidermolysis bullosa

    - Treatments for chronic wounds for patients with recessive dystrophic epidermolysis bullosa (In collaboration with Dr. Jean Tang and Dr. Peter Marinkovich)

    - Treatments for atopic dermatitis, psoriasis, and other inflammatory skin conditions

    Diagnostics:

    - Artificial intelligence approaches for melanoma and skin cancer early detection

    - Imaging mass spectrometry for skin cancer margin analysis and diagnosis

    I collaborate with other faculty within the Stanford Skin Innovation and Interventional Research Group (SIIRG) to conduct investigator initiated and sponsored clinical trials seeking to improve care for important dermatologic diseases

Latest information on COVID-19